The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bowman Jack L since 2006.
The trader's CIK number is 1014094.
At the time of the last reporting, Bowman Jack L was the Director of Celgene Corp /de/. (stock ticker symbol CELG).
Also see all insider trading activities at Celgene Corp /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | AVII | 5,000 | $31,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | CELG | 0 | $0 | 80,000 | $4,736,600 | 80,000 | $672,400 |
| 2006 | CELG | 0 | $0 | 140,000 | $6,970,880 | 140,000 | $588,720 |
1. Sarepta Therapeutics, Inc. (AVII)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-03-17 | AVII | Buy | 5,000 | 6.36 | 31,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-05-07 | CELG | Option Ex | 40,000 | 8.40 | 336,200 |
| 2007-05-07 | CELG | Sale | 40,000 | 62.76 | 2,510,360 |
| 2007-02-09 | CELG | Sale | 40,000 | 55.66 | 2,226,240 |
| 2007-02-09 | CELG | Option Ex | 40,000 | 8.40 | 336,200 |
| 2006-10-30 | CELG | Option Ex | 40,000 | 7.70 | 308,080 |
| 2006-10-30 | CELG | Sale | 40,000 | 49.42 | 1,976,720 |
| 2006-07-31 | CELG | Option Ex | 40,000 | 4.41 | 176,480 |
| 2006-07-31 | CELG | Sale | 40,000 | 47.57 | 1,902,840 |
| 2006-05-01 | CELG | Option Ex | 40,000 | 1.30 | 52,080 |
| 2006-05-01 | CELG | Sale | 40,000 | 41.94 | 1,677,560 |
| 2006-02-02 | CELG | Option Ex | 20,000 | 2.60 | 52,080 |
| 2006-02-02 | CELG | Sale | 20,000 | 70.69 | 1,413,760 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bowman Jack L (Director of Celgene Corp /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.